US LNG exports surge but will buyers in China turn up?
CHICAGO - GE HealthCare Technologies Inc. (NASDAQ:GEHC) has announced a cash dividend for the first quarter of 2025. Shareholders of record as of April 25, 2025, will receive a dividend of $0.035 per share, payable on May 15, 2025. The company’s dividend yield stands at 0.17%, with a notable dividend growth of 16.67% over the last twelve months.
The company, with a history spanning over 125 years, is a leading provider of medical technology and pharmaceutical diagnostics. GE HealthCare’s business, currently valued at $37.04 billion by market capitalization, employs approximately 53,000 people worldwide. According to InvestingPro analysis, the company trades at an attractive PEG ratio of 0.43, suggesting undervaluation relative to its growth prospects. Their work focuses on enhancing efficiency in hospitals and health systems, improving the effectiveness of clinicians, and refining therapies to ensure patients receive precise and compassionate care.
GE HealthCare’s portfolio includes Imaging, Advanced Visualization Solutions, Patient Care Solutions, and Pharmaceutical Diagnostics, all aimed at improving patient care from the initial screening and diagnosis to therapy and monitoring. The company emphasizes its commitment to innovation, particularly in AI-enabled solutions and services, and data analytics to advance healthcare. With a robust gross profit margin of 41.71% and annual revenue of $19.67 billion, the company demonstrates strong financial performance. For deeper insights into GE HealthCare’s financial health and growth potential, InvestingPro subscribers have access to exclusive analysis and detailed metrics.
Recently, GE HealthCare was recognized as one of the 2025 Fortune World’s Most Admired Companies, underscoring its reputation in the healthcare industry. The company remains dedicated to its vision of a world where healthcare has no limits, continually working towards better outcomes for patients and providers alike. With a solid P/E ratio of 19.67 and consistent profitability, GE HealthCare continues to demonstrate its market leadership in the healthcare equipment sector.
This announcement is based on a press release statement from GE HealthCare Technologies Inc.
In other recent news, GE HealthCare has reported its fourth-quarter sales results, showing a 2% year-over-year increase to $5.32 billion, aligning with consensus estimates. The company’s earnings per share for the quarter reached $1.45, surpassing the anticipated $1.26. Orders grew by 6% year-over-year, and the book-to-bill ratio was noted at 1.09 times, marking a strong performance since the company became publicly traded. Jefferies analyst Matthew Taylor raised the price target for GE HealthCare to $110, maintaining a Buy rating, while Stifel analysts also increased their price target to $104, reflecting positive sentiment.
In collaboration news, GE HealthCare has partnered with NVIDIA to advance AI imaging technologies, focusing on autonomous X-ray and ultrasound systems to ease the workload on healthcare professionals. The company also unveiled its Genesis portfolio, a cloud-based suite aimed at improving healthcare efficiency and reducing costs. This cloud-first strategy is part of GE HealthCare’s goal to triple its cloud-enabled products by 2028. Additionally, GE HealthCare is recognized as a ’pre-breakout candidate’ by BTIG, highlighting its potential within the healthcare sector, which is currently the top performer in the S&P 500.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.